{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:17:11Z","timestamp":1773296231497,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T00:00:00Z","timestamp":1355961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s12185-012-1244-1","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T07:07:23Z","timestamp":1355900843000},"page":"117-124","source":"Crossref","is-referenced-by-count":23,"title":["Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"97","author":[{"given":"Ding-Bao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Jing","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan-Hua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,20]]},"reference":[{"key":"1244_CR1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","volume":"1","author":"TE Starzl","year":"1984","unstructured":"Starzl TE, Nalesnik MA, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet. 1984;1:583\u20137.","journal-title":"Lancet"},{"key":"1244_CR2","first-page":"343","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Webber SA, Chadburn A, et al. Post-transplant lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 343\u20139."},{"issue":"4","key":"1244_CR3","first-page":"209","volume":"35","author":"YN Zhang","year":"2006","unstructured":"Zhang YN, Zhou XG, Wang CZ, et al. Clinicopathologic study of post-transplant lymphoproliferative disorders. Chin J Pathol. 2006;35(4):209\u201311.","journal-title":"Chin J Pathol"},{"key":"1244_CR4","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/ndt\/gfq231","volume":"25","author":"K Mucha","year":"2010","unstructured":"Mucha K, Foroncewicz B, Ziarkiewicz-Wroblewska B, et al. Post-transplant lymphoproliferative disorders in view of the new WHO classification: a more rational approach to a protean disease? Nephrol Dial Transplant. 2010;25:2089\u201398.","journal-title":"Nephrol Dial Transplant"},{"key":"1244_CR5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","volume":"4","author":"G Opelz","year":"2003","unstructured":"Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2003;4:222\u201330.","journal-title":"Am J Transplant"},{"key":"1244_CR6","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(05)80084-4","volume":"342","author":"G Opelz","year":"1993","unstructured":"Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993;342:1514\u20136.","journal-title":"Lancet"},{"key":"1244_CR7","first-page":"2208","volume":"94","author":"RE Curtis","year":"1999","unstructured":"Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94:2208\u201316.","journal-title":"Blood"},{"key":"1244_CR8","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/bmt.2010.272","volume":"46","author":"M Hoegh-Petersen","year":"2011","unstructured":"Hoegh-Petersen M, Goodyear D, Geddes MN, et al. High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts. Bone Marrow Transplant. 2011;46:1104\u201312.","journal-title":"Bone Marrow Transplant"},{"key":"1244_CR9","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.bbmt.2011.05.008","volume":"17","author":"N Kamani","year":"2011","unstructured":"Kamani N, Kumar S, Hassebroek A, et al. Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2011;17:1783\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"1244_CR10","first-page":"996","volume":"46","author":"LP Xu","year":"2007","unstructured":"Xu LP, Huang XJ, Liu DH, et al. A clinical study of lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation. Chin J Intern Med. 2007;46(12):996\u20139.","journal-title":"Chin J Intern Med"},{"issue":"11","key":"1244_CR11","first-page":"955","volume":"49","author":"LP Xu","year":"2010","unstructured":"Xu LP, Liu DH, Liu KY, et al. The efficacy and safety of donor lymphocyte infusion to treat Epstein\u2013Barr virus associated lymphoproliferative diseases after allogeneic hematopoietic stem cell transplantation. Chin J Intern Med. 2010;49(11):955\u20138.","journal-title":"Chin J Intern Med"},{"issue":"12","key":"1244_CR12","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1097\/01.pas.0000213317.59176.d2","volume":"30","author":"LR Johnson","year":"2006","unstructured":"Johnson LR, Nalesnik MA, Swerdlow SH. Impact of Epstein\u2013Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders. A histogenetic study. Am J Surg Pathol. 2006;30(12):1604\u201312.","journal-title":"Am J Surg Pathol"},{"key":"1244_CR13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.5858\/2007-131-1209-TCSOPL","volume":"131","author":"L Tsao","year":"2007","unstructured":"Tsao L, His ED. The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders. Arch Pathol Lab Med. 2007;131:1209\u201318.","journal-title":"Arch Pathol Lab Med"},{"key":"1244_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/230173","volume":"2012","author":"HAH Ibrahim","year":"2012","unstructured":"Ibrahim HAH, Naresh KN. Posttransplant lymphoproliferative disorders. Adv Hematol. 2012;2012:1\u201311.","journal-title":"Adv Hematol"},{"issue":"2","key":"1244_CR15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/blood.V85.2.552.552","volume":"85","author":"DM Knowles","year":"1995","unstructured":"Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85(2):552\u201365.","journal-title":"Blood"},{"issue":"2","key":"1244_CR16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0046-8177(96)90369-X","volume":"27","author":"TT Wu","year":"1996","unstructured":"Wu TT, Swerdlow SH, Locker J, et al. Recurrent Epstein\u2013Barr virus-associated lesions in organ transplant recipients. Hum Pathol. 1996;27(2):157\u201364.","journal-title":"Hum Pathol"},{"key":"1244_CR17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1365-2559.2007.02870.x","volume":"51","author":"J Borenstein","year":"2007","unstructured":"Borenstein J, Pezzella F, Gatter KC. Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders. Histopathology. 2007;51:774\u20137.","journal-title":"Histopathology"},{"issue":"7","key":"1244_CR18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3324\/haematol.2010.039214","volume":"96","author":"R Trappe","year":"2011","unstructured":"Trappe R, Zimmermann H, Fink S, et al. Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferative, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases. Haematologica. 2011;96(7):1067\u201371.","journal-title":"Haematologica"},{"key":"1244_CR19","first-page":"264","volume-title":"WHO classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"NL Harris","year":"2001","unstructured":"Harris NL, Swerdlow SH, Frizzera GF, et al. Post-transplant lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, et al., editors. WHO classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. p. 264\u20139."},{"issue":"6","key":"1244_CR20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/PAS.0b013e3182190999","volume":"35","author":"SE Gibson","year":"2011","unstructured":"Gibson SE, Swerdlow SH, Craig FE, et al. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorders? Am J Surg Pathol. 2011;35(6):807\u201315.","journal-title":"Am J Surg Pathol"},{"key":"1244_CR21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/TP.0b013e3181c69855","volume":"89","author":"G Opelz","year":"2010","unstructured":"Opelz G, Dohler B. Impact of HLA mismatching on incidence of posttransplant at non-Hodgkin lymphoma after kidney transplantation. Transplantation. 2010;89:567\u201372.","journal-title":"Transplantation"},{"issue":"20","key":"1244_CR22","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Gilbert ES, Rizzo JD, et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood. 2009;113(20):4992\u20135001.","journal-title":"Blood"},{"issue":"6","key":"1244_CR23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12185-012-1056-3","volume":"95","author":"T Kamiura","year":"2012","unstructured":"Kamiura T, Miyamoto T, Kawano N, et al. Successful treatment by donor lymphocyte infusion of adult T-cell leukemia\/lymphoma relapse following allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2012;95(6):725\u201330.","journal-title":"Int J Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1244-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-012-1244-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1244-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T20:20:21Z","timestamp":1643919621000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-012-1244-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,20]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1007\/s12185-012-1244-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,20]]}}}